
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on the Martin Zweig's Growth Investor model, which favors growth stocks with accelerating earnings and sales, reasonable valuations, and low debt; UNH passes most of the model's tests, including P/E ratio, revenue growth in relation to EPS growth, and sales growth rate, but fails in areas such as earnings persistence and long-term EPS growth.
UnitedHealth Group (UNH) scores 69% under Validea's Martin Zweig Growth Investor model, a strategy focused on companies with persistent, accelerating earnings and sales growth, reasonable valuations, and low debt. This rating is below the 80% threshold that typically signals strategy interest. UNH exhibits positive attributes by meeting criteria for its P/E ratio, revenue growth in relation to EPS growth, sales growth rate, and current quarter earnings, including accelerated EPS growth compared to both the prior three quarters and its historical growth rate. Insider transactions also pass the model's screen. However, the company fails on several key growth consistency metrics: quarterly earnings one year ago, earnings growth rate for the past several quarters, earnings persistence, and long-term EPS growth. These deficiencies, particularly the lack of earnings persistence and unfavorable long-term EPS growth outlook, significantly impact its score within a model that specifically targets these characteristics, presenting a mixed fundamental picture where recent momentum contrasts with concerns about sustained growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment